KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 150 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $8,243,000 | -21.6% | 826,000 | 0.0% | 1.10% | -32.6% |
| Q1 2015 | $10,515,000 | -25.7% | 826,000 | -17.4% | 1.62% | -25.5% |
| Q4 2014 | $14,150,000 | +2.9% | 1,000,000 | 0.0% | 2.18% | -22.8% |
| Q3 2014 | $13,750,000 | -37.5% | 1,000,000 | -41.2% | 2.83% | -55.7% |
| Q4 2013 | $22,015,000 | – | 1,700,000 | – | 6.39% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $22,357,000 | 15.70% |
| VHCP Management, LLC | 1,000,273 | $17,045,000 | 8.86% |
| HARVEY CAPITAL MANAGEMENT INC | 915,800 | $15,605,000 | 6.22% |
| Baupost Group | 6,310,850 | $107,537,000 | 2.60% |
| SECTORAL ASSET MANAGEMENT INC | 3,537,590 | $60,281,000 | 2.48% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 587,504 | $10,011,000 | 2.31% |
| Knoll Capital Management, LLC | 200,000 | $3,408,000 | 1.76% |
| Camber Capital Management LP | 1,250,000 | $21,300,000 | 1.67% |
| NORTHPOINTE CAPITAL LLC | 877,875 | $14,958,000 | 1.52% |
| DAFNA Capital Management LLC | 100,000 | $1,704,000 | 1.46% |